Maximus, Inc. (NYSE:MMS) President Bruce Caswell sold 8,000 shares of the firm’s stock in a transaction on Tuesday, September 5th. The shares were sold at an average price of $60.23, for a total transaction of $481,840.00. Following the completion of the transaction, the president now directly owns 35,904 shares in the company, valued at $2,162,497.92. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Bruce Caswell also recently made the following trade(s):

  • On Wednesday, August 16th, Bruce Caswell sold 8,000 shares of Maximus stock. The shares were sold at an average price of $60.50, for a total transaction of $484,000.00.
  • On Thursday, August 10th, Bruce Caswell sold 8,000 shares of Maximus stock. The shares were sold at an average price of $59.83, for a total transaction of $478,640.00.
  • On Thursday, July 27th, Bruce Caswell sold 8,000 shares of Maximus stock. The shares were sold at an average price of $60.97, for a total transaction of $487,760.00.
  • On Wednesday, July 12th, Bruce Caswell sold 8,000 shares of Maximus stock. The shares were sold at an average price of $62.21, for a total transaction of $497,680.00.
  • On Friday, June 16th, Bruce Caswell sold 8,000 shares of Maximus stock. The shares were sold at an average price of $63.56, for a total transaction of $508,480.00.

Shares of Maximus, Inc. (MMS) opened at 60.62 on Friday. The stock has a 50 day moving average of $60.39 and a 200 day moving average of $61.35. Maximus, Inc. has a one year low of $43.69 and a one year high of $64.97. The stock has a market cap of $3.93 billion, a P/E ratio of 19.43 and a beta of 1.37.

Maximus (NYSE:MMS) last announced its quarterly earnings results on Thursday, August 3rd. The health services provider reported $0.79 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.76 by $0.03. Maximus had a net margin of 8.43% and a return on equity of 25.08%. The company had revenue of $600.40 million for the quarter, compared to analysts’ expectations of $614.12 million. During the same quarter in the previous year, the business posted $0.79 EPS. Maximus’s revenue was down 2.7% compared to the same quarter last year. On average, analysts forecast that Maximus, Inc. will post $3.13 EPS for the current year.

The firm also recently announced a quarterly dividend, which was paid on Thursday, August 31st. Shareholders of record on Tuesday, August 15th were given a $0.045 dividend. This represents a $0.18 dividend on an annualized basis and a yield of 0.30%. The ex-dividend date was Friday, August 11th. Maximus’s dividend payout ratio (DPR) is 5.73%.

TRADEMARK VIOLATION WARNING: This news story was reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this news story on another publication, it was copied illegally and reposted in violation of United States and international trademark & copyright legislation. The legal version of this news story can be viewed at https://www.thecerbatgem.com/2017/09/09/insider-selling-maximus-inc-mms-president-sells-481840-00-in-stock.html.

A number of large investors have recently modified their holdings of the business. BlackRock Inc. raised its position in Maximus by 22,491.0% in the 1st quarter. BlackRock Inc. now owns 6,503,511 shares of the health services provider’s stock worth $404,518,000 after buying an additional 6,474,723 shares during the last quarter. Vanguard Group Inc. raised its position in Maximus by 2.4% in the 2nd quarter. Vanguard Group Inc. now owns 5,669,026 shares of the health services provider’s stock worth $355,052,000 after buying an additional 130,839 shares during the last quarter. FMR LLC raised its position in Maximus by 10.4% in the 2nd quarter. FMR LLC now owns 4,658,584 shares of the health services provider’s stock worth $291,767,000 after buying an additional 438,025 shares during the last quarter. William Blair Investment Management LLC raised its position in Maximus by 14.7% in the 1st quarter. William Blair Investment Management LLC now owns 4,416,279 shares of the health services provider’s stock worth $274,693,000 after buying an additional 566,292 shares during the last quarter. Finally, Victory Capital Management Inc. raised its position in Maximus by 8.6% in the 2nd quarter. Victory Capital Management Inc. now owns 3,100,903 shares of the health services provider’s stock worth $194,210,000 after buying an additional 244,823 shares during the last quarter. 97.22% of the stock is owned by institutional investors and hedge funds.

Several analysts have recently commented on the stock. Robert W. Baird assumed coverage on shares of Maximus in a report on Sunday, September 3rd. They issued a “neutral” rating for the company. Zacks Investment Research downgraded shares of Maximus from a “buy” rating to a “hold” rating in a report on Wednesday, August 9th. Maxim Group set a $66.00 target price on shares of Maximus and gave the company a “hold” rating in a report on Thursday, August 3rd. BidaskClub downgraded shares of Maximus from a “hold” rating to a “sell” rating in a report on Monday, July 24th. Finally, Canaccord Genuity downgraded shares of Maximus from a “buy” rating to a “hold” rating and set a $62.00 target price for the company. in a report on Tuesday, July 4th. One investment analyst has rated the stock with a sell rating and nine have issued a hold rating to the company. Maximus currently has a consensus rating of “Hold” and a consensus price target of $62.43.

About Maximus

MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.

Insider Buying and Selling by Quarter for Maximus (NYSE:MMS)

Receive News & Stock Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related stocks with our FREE daily email newsletter.